目次
1. グローバル静脈内カテーテル市場 エグゼクティブサマリー
1.1. グローバル市場規模および予測（2022年～2032年）
1.2. 地域別概要
1.3. セグメント別概要
1.4. 主要トレンド
1.5. アナリストの推奨および結論
2. グローバル静脈内カテーテル市場の定義および調査前提条件
2.1. 調査目的
2.2. 市場定義
2.3. 調査の前提
2.4. 推定方法
2.5. 調査対象年
3. 世界の静脈内カテーテル市場のダイナミクス
3.1. 市場の推進要因
3.1.1. 慢性疾患の増加
3.1.2. 静脈内カテーテルソリューションの技術的進歩
3.1.3. 外科的処置の増加
3.2. 市場の課題
3.2.1. カテーテル関連感染症のリスク
3.2.2. 先進的な点滴システムのコスト高
3.3. 市場機会
3.3.1. 新興市場における普及の拡大
3.3.2. スマート点滴システムの統合
4. 世界の静脈内カテーテル業界分析
4.1. ポーターのファイブフォース分析
4.2. PESTEL分析
4.3. 業界トレンド
5. 世界の静脈内カテーテル市場規模および種類別予測（2022年～2032年）
5.1. 末梢カテーテル
5.2. 中心静脈カテーテル
6. 世界の静脈内カテーテル市場規模およびエンドユース別予測（2022年～2032年）
6.1. 病院薬局
6.2. ドラッグストア
6.3. オンラインポータル
7. 地域別静脈内カテーテル市場規模・予測（2022年～2032年）
7.1. 北米
7.2. ヨーロッパ
7.3. アジア太平洋
7.4. ラテンアメリカ
7.5. 中東およびアフリカ
8. 競合情報
8.1. 主要企業のSWOT分析
8.1.1. BD
8.1.2. Medtronic
8.1.3. Teleflex Incorporated
8.2. トップ市場戦略
8.3. 企業プロフィール
BD (Becton, Dickinson and Company)
Medtronic
Teleflex Incorporated
B. Braun SE
Boston Scientific Corporation
Terumo Medical Corporation
Nipro Europe Group Companies
Mediplus India Ltd
Sterimed Group
Angiplast Pvt Ltd
Medilivescare Manufacturing Pvt. Ltd.
9. 調査プロセス
9.1. 調査の属性
9.2. データマイニングと検証
This growth is driven by the increasing prevalence of chronic diseases, a rising geriatric population, and the expanding need for modern healthcare solutions. Intravenous catheters are indispensable in medical settings, enabling the precise delivery of medications, fluids, and nutrients directly into the bloodstream. Their role in addressing the growing demand for efficient and safe intravenous therapies in surgical, emergency, and chronic care environments underscores their market significance.
Technological advancements have further propelled the industry, with the emergence of smart IV therapy systems that provide real-time monitoring and control of infusions. These innovations aim to enhance patient outcomes while minimizing risks such as catheter-related infections and thrombosis. Safety-engineered catheters with antimicrobial coatings are also gaining traction, reflecting the sector's focus on patient safety and treatment quality. Additionally, increasing surgical procedures globally contribute to the market's upward trajectory, as IV catheters are essential for various clinical interventions.
Regional insights reveal that North America holds the largest market share due to its robust healthcare infrastructure and the presence of major industry players. In contrast, the Asia Pacific region is poised for the fastest growth, driven by an aging population, rising healthcare expenditures, and a surge in chronic disease cases.
Key market players are focused on expanding their portfolios and integrating advanced features, further enhancing the efficacy and safety of IV catheters. The competitive landscape is marked by significant investments in R&D and strategic collaborations, paving the way for innovative product launches and market expansion.
Major market players included in this report are:
• BD (Becton, Dickinson and Company)
• Medtronic
• Teleflex Incorporated
• B. Braun SE
• Boston Scientific Corporation
• Terumo Medical Corporation
• Nipro Europe Group Companies
• Mediplus India Ltd
• Sterimed Group
• Angiplast Pvt Ltd
• Medilivescare Manufacturing Pvt. Ltd.
The detailed segments and sub-segments of the market are explained below:
By Type:
• Peripheral Catheters
• Central Venous Catheters
By End Use:
• Hospital Pharmacies
• Drug Stores
• Online Portals
By Region:
• North America:
o U.S.
o Canada
• Europe:
o UK
o Germany
o France
o Italy
o Rest of Europe
• Asia Pacific:
o China
o Japan
o India
o South Korea
o Rest of Asia Pacific
• Latin America:
o Brazil
o Mexico
o Rest of Latin America
• Middle East & Africa:
o UAE
o South Africa
o Rest of Middle East & Africa
Years Considered for the Study:
• Historical Year: 2022
• Base Year: 2023
• Forecast Period: 2024 to 2032
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.
Table of Contents
1. Global Intravenous Catheters Market Executive Summary
1.1. Global Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.4. Key Trends
1.5. Analyst Recommendation & Conclusion
2. Global Intravenous Catheters Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.4. Estimation Methodology
2.5. Years Considered for the Study
3. Global Intravenous Catheters Market Dynamics
3.1. Market Drivers
3.1.1. Rising Chronic Disease Prevalence
3.1.2. Technological Advancements in IV Catheter Solutions
3.1.3. Increasing Surgical Procedures
3.2. Market Challenges
3.2.1. Risk of Catheter-Associated Infections
3.2.2. High Costs of Advanced IV Systems
3.3. Market Opportunities
3.3.1. Growing Adoption in Emerging Markets
3.3.2. Integration of Smart IV Systems
4. Global Intravenous Catheters Industry Analysis
4.1. Porter’s Five Forces Analysis
4.2. PESTEL Analysis
4.3. Industry Trends
5. Global Intravenous Catheters Market Size & Forecast by Type (2022-2032)
5.1. Peripheral Catheters
5.2. Central Venous Catheters
6. Global Intravenous Catheters Market Size & Forecast by End Use (2022-2032)
6.1. Hospital Pharmacies
6.2. Drug Stores
6.3. Online Portals
7. Global Intravenous Catheters Market Size & Forecast by Region (2022-2032)
7.1. North America
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. BD
8.1.2. Medtronic
8.1.3. Teleflex Incorporated
8.2. Top Market Strategies
8.3. Company Profiles
9. Research Process
9.1. Research Attributes
9.2. Data Mining & Validation
❖ 掲載企業 ❖
BD (Becton, Dickinson and Company)、Medtronic、Teleflex Incorporated、B. Braun SE、Boston Scientific Corporation、Terumo Medical Corporation、Nipro Europe Group Companies、Mediplus India Ltd、Sterimed Group、Angiplast Pvt Ltd、Medilivescare Manufacturing Pvt. Ltd.など
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
